MDGLMadrigal Pharmaceuticals, Inc.
$433.63-1.9% 1Y
$433.63
$412.3552 weeks$602.83
Is the price fair?
What MDGL's price assumes
Madrigal Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 7.80× revenue.
7.80
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 19.1
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 7.42
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 19.1
- EV / EBIToperating margin −25%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 7.42
- Market capitalisation23.1 million shares, counted Jul 27, 2026
- $10.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks